Atrial Fibrillation Trial, Recruiting NCT04814420 Sponsor: Tulane University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT04814420
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old.
  • You have been diagnosed with mild sleep apnea (breathing interruptions during sleep), confirmed by an overnight sleep study — and have no history of irregular heart rhythm (atrial fibrillation).
  • You have been diagnosed with moderate sleep apnea, confirmed by an overnight sleep study — and have no history of irregular heart rhythm (atrial fibrillation).
  • You have been diagnosed with severe sleep apnea, confirmed by an overnight sleep study — and have no history of irregular heart rhythm (atrial fibrillation).
  • You have mild sleep apnea and have been previously diagnosed with an irregular heart rhythm (atrial fibrillation) — previous heart scan (MRI) results may also be accepted.
  • You have severe sleep apnea and have been previously diagnosed with an irregular heart rhythm (atrial fibrillation) — previous heart scan (MRI) results may also be accepted.
  • You have no previous diagnosis of either sleep apnea or irregular heart rhythm (this would place you in the control group).

Who may not be able to join:

  • You have a history of heart failure, irregular heart rhythm (atrial fibrillation), a previous heart attack, or a heart valve problem.
  • You have previously had surgery on your heart or chest.
  • You have a serious lung condition such as severe COPD, severe asthma, high blood pressure in the lungs, or a type of sleep apnea caused by the brain rather than a blocked airway.
  • You are unable to have a special type of MRI scan — for example, because you are allergic to the dye used, have a pacemaker, a defibrillator (ICD), certain other implanted devices, or have poor kidney function (confirm with trial site).
  • You are pregnant.
  • You are not able to give your agreement (consent) to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amitabh Pandey, MD, Tulane University School of Medicine

Phone: 504-988-3072

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tulane University
Registry
ClinicalTrials.gov
Start date
12 July 2021
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of atrial fibrosis in the left atrium measured by DE-MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov